Natasha Pillay Smiley, DO

Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach. Orduña, P; Cansanay, RD; Erker, C; Ratterman, E; Schlosser, MP; Ronsley, R; Cacciotti, C; Cheng, S; Hukin, J; Aguilera, D; Rutkowski, S; Lassaletta, A; Bouffet, E; Lafay-Cousin, L. Pediatric Blood and Cancer. 2026; 73(5):e70181.

MEK inhibitor-induced dropped head syndrome in pediatrics. Gilene, S; Miller, C; Cronk, JC; Graham, RT; Gross, AM; Hummel, TR; Kotch, C; Mochizuki, AY; Raskin, S; Pillay-Smiley, N; De Blank, P. Neuro-Oncology Pediatrics. 2026; 2(2):wuag024.

An analysis of PD1 pathway activity in malignant pediatric central nervous system tumors: a pediatric brain tumor consortium study, PBTC-N13. Raskin, S; Yang, C; Lin, T; Yearley, J; Blumenschein, W; Pillay-Smiley, N; Lenzen, A; Partap, S; Fangusaro, J; Gururangan, S; Onar-Thomas, A; Fouladi, M; Dunkel, I; Mitchell, DA; Hwang, EI. Neuro-Oncology Pediatrics. 2026; 2(2):wuag020.

Re-irradiation practices and outcomes in patients with diffuse intrinsic pontine glioma (DIPG): A report from the International DIPG/DMG Registry. Smiley, NP; Lane, A; Webster, A; Blank, C; Hawkins, C; Hassall, T; Leach, J; Dorris, K; Jones, B; Hansford, JR; Zaghloul, M; Cheng, S; Hummel, TR; Hoffman, LM; Warren, KE. Neuro-Oncology Pediatrics. 2026; 2(2):wuag013.

A multi-institutional report of children with atypical teratoid rhabdoid tumor treated with intensive multimodal therapy. Margol, AS; Hoffman, LM; Ronsley, R; Tran, J; Malvar, J; Chi, Y-Y; Leary, S; Stevens, J; Faulk, KE; Salloum, R; Gilheeney, S; Szalontay, L; Reddy, AT; Dhall, G. Neuro-Oncology Practice. 2026; npag014.

IMMU-79. An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13. Raskin, S; Yang, C; Lin, T; Yearley, J; Blumenschein, W; Pillay-Smiley, N; Lenzen, A; Partap, S; Fangusaro, J; Gururangan, S; Onar-Thomas, A; Fouladi, M; Dunkel, I; Mitchell, D; Hwang, E. Neuro-Oncology. 2025; 27(Supplement_5):v221-v221.

BIOM-88. LEPTOMENINGEAL METASTASIS IN THE INTERNAL AUDITORY CANAL AS A PREDICTOR OF OUTCOMES FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS. Koch, A; Derinkuyu, B; Webster, A; Mochizuki, A; Pillay-Smiley, N; Graham, RT. Neuro-Oncology. 2025; 27(Supplement_5):v45-v45.

A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Fangusaro, J; Onar-Thomas, A; Young Poussaint, T; Lensing, S; Ligon, AH; Lindeman, N; Banerjee, A; Kilburn, LB; Lenzen, A; Pillay-Smiley, N; Jones, DTW; Stewart, CF; Fouladi, M; Dunkel, IJ. Neuro-Oncology. 2025; 27(9):2415-2428.

Elevated Bromide Levels Due to Tazemetostat Therapy Treated With Salt and Water Supplementation in Two Children With Atypical Teratoid Rhabdoid Tumor. Galletta, TJ; Benoit, SW; Markham, J; Pillay-Smiley, N; Queen, K; Graham, RT. Pediatric Blood and Cancer. 2025; 72(8):e31803.

MDB-03. Outcome of Group 4 medulloblastomas of early childhood treated with high dose chemotherapy and craniospinal irradiation sparing approach. Cansanay, RD; Erker, C; Ratterman, E; Schlosser, MP; Ronsley, R; Cacciotti, C; Cheng, S; Hukin, J; Magimairajan, V; Pillay-Smiley, N; Rutkowski, S; Lassaletta, A; Bouffet, E; Lafay-Cousin, L. Neuro-Oncology Pediatrics. 2025; 1(Supplement_1).